Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 147

Sort by

Sort Order Select

Journal Articles

CD162 Is a Key E-Selectin Receptor Promoting Acute Myeloid Leukemia Chemo-Resistance in the Bone Marrow Niche

Johanna D Erbani, Joshua Tay, PhD, Valerie Barbier, Masters, Jean-Pierre Levesque, PhD, John L. Magnani, PhD, Ingrid G Winkler, PhD

Blood (2019) 134 (Supplement_1): 907.

https://doi.org/10.1182/blood-2019-132233

Published: 2019

Journal Articles

Quality Improvement Initiatives to Improve Transfusion Safety and Efficiency for Patients Receiving Daratumumab

Richard Curtis Godby, MD, Tammy Gray, BS, Hollie Christopher, BS, MLS, Lance A. Williams, III, MD, Marisa B. Marques, MD

Blood (2019) 134 (Supplement_1): 2100.

https://doi.org/10.1182/blood-2019-126958

Published: 2019

Journal Articles

The Mystery of "Magic Blood" - Familial Macrothrombocytopenia Associated with a Novel Variant in GP1BA Gene

Zhaohui Liao Arter, MD, Caitlin Yatogo, MS, CGC, Michael C. Chicka, PhD, Jeffrey L. Berenberg, MD

Blood (2019) 134 (Supplement_1): 2380.

https://doi.org/10.1182/blood-2019-122384

Published: 2019

Journal Articles

Alterations in Sphingomyelin Metabolism Influences Tissue Factor Procoagulant Activity and the Release of TF-Positive Microvesicles

Jue Wang, PhD, Usha Pendurthi, PhD, L. Vijaya Mohan Rao, PhD

Blood (2019) 134 (Supplement_1): 1103.

https://doi.org/10.1182/blood-2019-125933

Published: 2019

Journal Articles

Desialylation and Apoptosis Crosstalk to Modulate Platelet Clearance

Renata Grozovsky, PhD, Cameron Fraser, BS, Karin M. Hoffmeister, MD, Kristopher Sarosiek, PhD, Silvia Giannini, PhD

Blood (2019) 134 (Supplement_1): 1055.

https://doi.org/10.1182/blood-2019-122184

Published: 2019

Journal Articles

Hypogammaglobulinemia and Its Implications in Patients Treated with Daratumumab: A Single Institution Experience

Yonette Paul, MD MBBS, Luis E. Aguirre, MD, Fahmin Basher, MD PhD, Feng Miao, MS, Tulay Koru-Sengul, PhD, James E. Hoffman, MD

Blood (2019) 134 (Supplement_1): 3131.

https://doi.org/10.1182/blood-2019-127247

Published: 2019

Journal Articles

Novel Allosteric Inhibitors of Heat Shock Protein 70 As Agents to Probe Protein Homeostasis and Overcome Proteasome Inhibitor Resistance in Multiple Myeloma

Ian Ferguson, BA, Christine Lam, BA, Margarette C. Mariano, MS, Donghui Wang, BA, Paul Phojanakong, BA, Sami Toumivaara, PhD, Hao Shao, PhD, Byron C Hann, MD PhD, Jason Gestwicki, PhD, Arun P Wiita, MDPhD

Blood (2018) 132 (Supplement 1): 3212.

https://doi.org/10.1182/blood-2018-99-117401

Published: 2018

Journal Articles

Sialic Acid Content on Platelet Surface Glycoproteins Modulates Thrombin-Induced Activation

Alexander Prete, Alexander Urtula, Renata Grozovsky, PhD

Blood (2018) 132 (Supplement 1): 3730.

https://doi.org/10.1182/blood-2018-99-119303

Published: 2018

Journal Articles

Identification and Characterization of EBV Genome in NKT Cell Lymphoma

Yi Su, MD, Xi Yang, Hai Yi, MD, Fangyi Fan, Haoping Sun, Sihan Lai, Ting Niu, MD PhD

Blood (2018) 132 (Supplement 1): 5304.

https://doi.org/10.1182/blood-2018-99-118710

Published: 2018

Journal Articles

Evaluation of Re-Intensification of Daratumumab to Weekly or Biweekly Dosing Schedule

Elaine Xiang, PharmD, Hillary Prescott, PharmD, Jacob Laubach, MD, Paul Richardson, Kaitlen Reyes, NP, Irene M. Ghobrial, MD, Houry Leblebjian, PharmD

Blood (2018) 132 (Supplement 1): 2024.

https://doi.org/10.1182/blood-2018-99-111191

Published: 2018

Journal Articles

Targeting the Glyco-Antigen CD75s with the Tetravalent, Fc-Engineered Antibody 'Ebu-141 Tetra' Induces Potent Killing of B Cell Lymphoma and Plasma Cell Tumors

Katja Klausz, PhD, Amir Karimzadeh-Tabrizi, Malena Buck, Steffen Krohn, Anna-Kathrin Otte, PhD, Christian Kellner, PhD, Giorgio Alberto Croci, MD, Wolfram Klapper, MD, Matthias Peipp, PhD, Martin Gramatzki, MD

Blood (2018) 132 (Supplement 1): 4178.

https://doi.org/10.1182/blood-2018-99-118068

Published: 2018

Journal Articles

Two Novel Compound Heterozygous Pathogenic Variants in P2YR12 gene

Arnaud Dupuis, PhD, Doris Böckelmann, PhD, Patricia Laeuffer, Katharina Neubauer, PhD, Christian Gachet, MD PhD, Barbara Zieger

Blood (2018) 132 (Supplement 1): 1154.

https://doi.org/10.1182/blood-2018-99-112833

Published: 2018

Journal Articles

Identification of a Novel Heterozygous Mutation ( c.2213T>G;p.Leu738Arg ) in Platelet Glycoprotein ITGB3 gene in a Patient with Glanzmann's Thrombasthenia

Candido E. Rivera, MD, Prakash Vishnu, MD, Gretchen Schaef Johns, MD, Rajiv K. Pruthi, M.B.B.S., Dong Chen, MD PhD

Blood (2018) 132 (Supplement 1): 1158.

https://doi.org/10.1182/blood-2018-99-117995

Published: 2018

Journal Articles

Phase I-IIa Clinical Trial to Assess Safety and Efficacy of MLM-CAR44.1, a CD44v6 Directed CAR-T in Relapsed/Refractory Acute Myeloid Leukemia (AML) and Multiple Myeloma (MM)

Matteo Giovanni Carrabba, MD, Monica Casucci, PhD, Michael Hudecek, MD, Concetta Quintarelli, PhD, Javier Briones, MD, Roman Hajek, MD PhD, Jorge Sierra, MD, Franco Locatelli, Hermann Einsele, MD PhD, Claudio Bordignon, MD, Fabio Ciceri, MD, Catia Traversari, PhD

Blood (2018) 132 (Supplement 1): 5790.

https://doi.org/10.1182/blood-2018-99-117974

Published: 2018

Journal Articles

All Itching Is Not Benign; A Case of Refractory Hypereosinophilic Syndrome Treated with Off Label CD52 Inhibitor-Alemtuzumab

Rehan Ansari, MD, Elva Nora Osuna Salazar, MD, Nabeel Sarhill, MD, Laura E Garcia, MD, James Hanley, MD

Blood (2018) 132 (Supplement 1): 5485.

https://doi.org/10.1182/blood-2018-99-118271

Published: 2018

Journal Articles

Clinical, Laboratory, and Genetic Risk Factors for Thrombosis in Sickle Cell Disease

Andrew Srisuwananukorn, MD, Rasha Raslan, MD, Xu Zhang, PhD, Binal N. Shah, PhD, Jin Han, PharmD, PhD, Michel Gowhari, DO, Shivi Jain, MD, Robert E. Molokie, MD, Victor R. Gordeuk, MD, Santosh L. Saraf, MD

Blood (2018) 132 (Supplement 1): 9.

https://doi.org/10.1182/blood-2018-99-115128

Published: 2018

Journal Articles

All-Trans Retinoic Acid (ATRA) up-Regulates Cell Surface CD38 Expression Which Promotes Pro-Tumoral Mitochondrial Trafficking from Stromal Cells to Multiple Myeloma

Christopher Richard Marlein, BSc, Rebecca H Horton, Rachel E Piddock, BSc, Jayna J Mistry, BSc, Charlotte Hellmich, MBBChir, BSc, MRCP, Cesar A. Gomez, MD PhD FRCPath, Kristian Bowles, MBBS, PhD, Stuart Rushworth, PhD BSc

Blood (2018) 132 (Supplement 1): 3153.

https://doi.org/10.1182/blood-2018-99-110323

Published: 2018

Journal Articles

GPVI Intracellular Signaling Is Activated in Platelets from Patients with Essential Thrombocythemia

Gabriela S. Hobbs, MD, Vanessa Eldridge, MS, Richard M. Stone, MD, Martha Wadleigh, MD, David P. Steensma, MD, Gregory A. Abel, MD, Daniel J. DeAngelo, MD, Ann Mullally, MD, Renata Grozovsky, PhD

Blood (2017) 130 (Supplement 1): 1025.

https://doi.org/10.1182/blood.V130.Suppl_1.1025.1025

Published: 2017

Journal Articles

Investigating the Effects of Anti-CD200 Therapy for Childhood ALL

Paraskevi Diamanti, BSc, PhD, Charlotte V. Cox, BSc, Benjamin C Ede, BSc, Penka S. Petrova, PhD, Robert A. Uger, PhD, Allison Blair, PhD BSc

Blood (2016) 128 (22): 4021.

https://doi.org/10.1182/blood.V128.22.4021.4021

Published: 2016

Journal Articles

A Novel CD34 / ETO2 / Ifngr gene Regulatory Axis Is Implicated in Poor-Prognosis Cases of t(8;21) AML

Nickolas Steinauer, BA, Madeline Wong, PhD, Chun Guo, M.S., Jinsong Zhang, PhD

Blood (2016) 128 (22): 1691.

https://doi.org/10.1182/blood.V128.22.1691.1691

Published: 2016

NARROW

CD162 Is a Key E-Selectin Receptor Promoting Acute Myeloid Leukemia Chemo-Resistance in the Bone Marrow Niche

Quality Improvement Initiatives to Improve Transfusion Safety and Efficiency for Patients Receiving Daratumumab

The Mystery of "Magic Blood" - Familial Macrothrombocytopenia Associated with a Novel Variant in GP1BA Gene

Alterations in Sphingomyelin Metabolism Influences Tissue Factor Procoagulant Activity and the Release of TF-Positive Microvesicles

Desialylation and Apoptosis Crosstalk to Modulate Platelet Clearance

Hypogammaglobulinemia and Its Implications in Patients Treated with Daratumumab: A Single Institution Experience

Novel Allosteric Inhibitors of Heat Shock Protein 70 As Agents to Probe Protein Homeostasis and Overcome Proteasome Inhibitor Resistance in Multiple Myeloma

Sialic Acid Content on Platelet Surface Glycoproteins Modulates Thrombin-Induced Activation

Identification and Characterization of EBV Genome in NKT Cell Lymphoma

Evaluation of Re-Intensification of Daratumumab to Weekly or Biweekly Dosing Schedule

Targeting the Glyco-Antigen CD75s with the Tetravalent, Fc-Engineered Antibody 'Ebu-141 Tetra' Induces Potent Killing of B Cell Lymphoma and Plasma Cell Tumors

Two Novel Compound Heterozygous Pathogenic Variants in P2YR12 gene

Identification of a Novel Heterozygous Mutation ( c.2213T>G;p.Leu738Arg ) in Platelet Glycoprotein ITGB3 gene in a Patient with Glanzmann's Thrombasthenia

Phase I-IIa Clinical Trial to Assess Safety and Efficacy of MLM-CAR44.1, a CD44v6 Directed CAR-T in Relapsed/Refractory Acute Myeloid Leukemia (AML) and Multiple Myeloma (MM)

All Itching Is Not Benign; A Case of Refractory Hypereosinophilic Syndrome Treated with Off Label CD52 Inhibitor-Alemtuzumab

Clinical, Laboratory, and Genetic Risk Factors for Thrombosis in Sickle Cell Disease

All-Trans Retinoic Acid (ATRA) up-Regulates Cell Surface CD38 Expression Which Promotes Pro-Tumoral Mitochondrial Trafficking from Stromal Cells to Multiple Myeloma

GPVI Intracellular Signaling Is Activated in Platelets from Patients with Essential Thrombocythemia

Investigating the Effects of Anti-CD200 Therapy for Childhood ALL

A Novel CD34 / ETO2 / Ifngr gene Regulatory Axis Is Implicated in Poor-Prognosis Cases of t(8;21) AML

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only